Exact Mass: 510.0497706
Exact Mass Matches: 510.0497706
Found 49 metabolites which its exact mass value is equals to given mass value 510.0497706,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Leinamycin
C22H26N2O6S3 (510.09529360000005)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
2-O-[2-O-(alpha-D-Mannopyranosyl)-alpha-D-glucopyranosyl]-3-phospho-D-glycerate
C15H27O17P (510.09858220000007)
Daidzein 4'-glucuronide-7-sulfate
Daidzein 7-glucuronide-4'-sulfate
IB-Meca
Lormetazepam glucuronide
3,3,4,5,5,7,8-heptahydroxyl flavone-8-O-beta-D-glucuronopyranoside|floramanoside C
C21H18O15 (510.06456779999996)
Citicoline
Donor of choline in biosynthesis of choline-containing phosphoglycerides.
sodium,formaldehyde,4-(4-hydroxyphenyl)sulfonylphenol,naphthalene-1-sulfonate
C23H19NaO8S2 (510.04190140000003)
Kresol-Schaeffersalz-Formaldehydkondensationsprodukt, sulfiert
sodium 2,5-dichloro-4-[[5-cyano-2,6-bis[(2-hydroxyethyl)amino]-4-methyl-3-pyridyl]azo]benzenesulphonate
C17H17Cl2N6NaO5S (510.0255852000001)
1H,1H,2H,2H-PERFLUOROOCTYLTRIETHOXYSILANE
C14H19F13O3Si (510.0895819999999)
3-(2-Pyridyl)-5,6-diphenyl-1,2,4-triazine-p,p′-disulfonic acid monosodium salt hydrate
IB-MECA
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Piclidenoson (IB-MECA) is a first-in-class, orally active and selective A3 adenosine receptor (A3AR) agonist. Piclidenoson exhibits antiproliferative effect and induces apoptosis in different cancer cell types like melanoma, leukemia. Piclidenoson can be used for the research of autoimmune inflammatory diseases and COVID-19[1][2][3][4].
sodium,formaldehyde,4-(4-hydroxyphenyl)sulfonylphenolate,naphthalene-1-sulfonic acid
C23H19NaO8S2 (510.04190140000003)
450191S
C21H21Cl3N6O3 (510.07406460000004)
Rilmazafone hydrochloride (450191S) is a benzodiazepine (omega) ligand[1].
bis(4-propan-2-ylphenyl)iodanium,hexafluorophosphate
C18H22F6IP (510.04080039999997)
N-(TRIMETHOXYSILYLPROPYL)ETHYLENEDIAMINETRIACETATE, TRIPOTASSIUM SALT, 30 in water
C14H25K3N2O9Si (510.02404999999993)
2-[2-(2,4-dichloro-5-propan-2-yloxyanilino)-2-oxoethyl]sulfinyl-N-[3-(trifluoromethyl)phenyl]acetamide
C20H19Cl2F3N2O4S (510.03946300000007)
Citicoline sodium
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics D002491 - Central Nervous System Agents > D018697 - Nootropic Agents
Lormetazepam glucuronide
(2S,3R,5R)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-N-methyl-2-oxolanecarboxamide
bis[2-(3-chloro-4-methoxyanilino)-2-oxoethyl] (E)-but-2-enedioate
1-(4-Chloro-3-fluorophenyl)-3-[[4-[[(4-chloro-3-fluorophenyl)carbamothioylamino]methyl]phenyl]methyl]thiourea
7-Hydroxy-8-{[4-(phenyldiazenyl)phenyl]diazenyl}naphthalene-1,3-disulfonate
2-[(2-Hydroxynaphthalen-1-yl)diazenyl]-5-[(4-sulfonatophenyl)diazenyl]benzene-1-sulfonate
2-O-[alpha-D-mannopyranosyl-(1->2)-alpha-D-glucopyranosyl]-3-O-phospho-D-glyceric acid
C15H27O17P (510.09858220000007)
3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-N-methyl-2-oxolanecarboxamide
Citicoline (sodium)
Citicoline sodium salt is an intermediate in the synthesis of phosphatidylcholine which is a component of cell membranes and also exerts neuroprotective effects. Citicoline sodium salt is an intermediate in the synthesis of phosphatidylcholine which is a component of cell membranes and also exerts neuroprotective effects.
(9z,13z,15z)-3',4,11-trihydroxy-2,3',9-trimethyl-4',12-dioxo-19-thia-3,20-diazaspiro[bicyclo[15.2.1]icosane-6,2'-[1,5]dithiolane]-1(20),3,9,13,15,17-hexaen-1'-ium-1'-olate
C22H26N2O6S3 (510.09529360000005)
4,11-dihydroxy-12-{11-hydroxy-10-oxo-8,16-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,11,13,15-octaen-12-yl}-8,16-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,11,13,15-octaen-10-one
6,9,10-trihydroxy-19,20-dimethoxy-23-methyl-4,22-dioxa-13,14-dithia-3,23-diazahexacyclo[10.10.2.0¹,¹⁵.0³,¹².0⁵,¹⁰.0¹⁶,²¹]tetracosa-7,16,18,20-tetraene-2,24-dione
C21H22N2O9S2 (510.07666820000003)
(1r,5s,6r,9r,10s,12r,15r)-6,9,10-trihydroxy-19,20-dimethoxy-23-methyl-4,22-dioxa-13,14-dithia-3,23-diazahexacyclo[10.10.2.0¹,¹⁵.0³,¹².0⁵,¹⁰.0¹⁶,²¹]tetracosa-7,16,18,20-tetraene-2,24-dione
C21H22N2O9S2 (510.07666820000003)
(1'r,2r,3'r,6s,9e,11r,13z,15e)-3',4,11-trihydroxy-2,3',9-trimethyl-4',12-dioxo-19-thia-3,20-diazaspiro[bicyclo[15.2.1]icosane-6,2'-[1,5]dithiolane]-1(20),3,9,13,15,17-hexaen-1'-ium-1'-olate
C22H26N2O6S3 (510.09529360000005)
(2r,3'r,6r,9e,11r,13e,15z)-3',4,11-trihydroxy-2,3',9-trimethyl-4',12-dioxo-19-thia-3,20-diazaspiro[bicyclo[15.2.1]icosane-6,2'-[1,5]dithiolane]-1(20),3,9,13,15,17-hexaen-1'-ium-1'-olate
C22H26N2O6S3 (510.09529360000005)
(2r,3'r,6r,9z,11r,13z,15e)-3',4,11-trihydroxy-2,3',9-trimethyl-4',12-dioxo-19-thia-3,20-diazaspiro[bicyclo[15.2.1]icosane-6,2'-[1,5]dithiolane]-1(20),3,9,13,15,17-hexaen-1'-ium-1'-olate
C22H26N2O6S3 (510.09529360000005)
3',4,11-trihydroxy-2,3',9-trimethyl-4',12-dioxo-19-thia-3,20-diazaspiro[bicyclo[15.2.1]icosane-6,2'-[1,5]dithiolane]-1(20),3,9,13,15,17-hexaen-1'-ium-1'-olate
C22H26N2O6S3 (510.09529360000005)